Depixus

📍 Paris, France🗓 Founded 2012👥 62 employees💰 Last funded Jun 2020
Biotechnology Research🌐 depixus.com
Website LinkedIn
Depixus® is pioneering a powerful new technology based on magnetic force spectroscopy, that reveals biomolecular interactions. MAGNA™ enables researchers to decode disease mechanisms and unlock a faster route to more effective therapies. Our MAGNA technology goes beyond decoding the static genetic code to reveal the dynamics of the genome that control health and disease.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Depixus?
Depixus has 1 investors on record on gritt.io and 1 late-stage investors.
When did Depixus last raise funding?
The most recent investment in Depixus recorded on gritt.io was in June 2020.
When was Depixus founded?
Depixus was founded in 2012.
What industry is Depixus in?
Depixus operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Depixus based?
Depixus is headquartered in Paris, France.